BeOne Medicines (ONC) Other Working Capital Changes (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Working Capital Changes data on file, last reported at -$15.3 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 48.65% year-over-year to -$15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 150.12% YoY) and the FY2025 annual result came in at -$3.0 million, down 126.45% from the prior year.
• Other Working Capital Changes declined to -$15.3 million in Q1 2026 per ONC's latest filing, from $52.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $90.2 million in Q3 2023 and bottomed at -$80.3 million in Q2 2022.
• The 5-year median for Other Working Capital Changes is $3.5 million (2022), against an average of -$235941.2.
• The widest annual swing landed in 2022, when Other Working Capital Changes soared 1568.31%; it then slumped 1033.01% in 2023.
• Tracing ONC's Other Working Capital Changes over 5 years: stood at $39.4 million in 2022, then slumped by 159.93% to -$23.6 million in 2023, then surged by 187.59% to $20.7 million in 2024, then jumped by 153.02% to $52.3 million in 2025, then slumped by 129.2% to -$15.3 million in 2026.
• Per Business Quant, the three latest ONC Other Working Capital Changes figures stand at -$15.3 million (Q1 2026), $52.3 million (Q4 2025), and -$70.4 million (Q3 2025).

Peer Comparison